Demographic and Clinical Characteristics | |
---|---|
Number | 170 |
Age (Years) | 66 ± 13 |
Gender (% Male) | 68 |
Ethnicity (%White) | 84 |
Predialysis weight (kg) | 73.7 ± 15.4 |
Diabetes (%) | 26 |
Cardiac Disease (%) | 45 |
Cancer (%) | 13 |
Charlson Comorbidity Index | 5.7 ± 2.1 |
RRT Vintage (months) | 42 [48] |
Biochemical Parameters | |
Serum Sodium (mmol/l) | 136.9 ± 3.2 |
Serum albumin (g/l) | 35.5 ± 4.6 |
Haemoglobin level (g/l) | 11.6 ± 1.4 |
High CRP >5Â mg/l (%) | 48 |
KRU (ml/min) | 0.3 [1.5] |
KRU > 1 ml/min (%) | 33 |
Dialysis Parameters | |
Dialysis session time (minutes) | 184 ± 30 |
Sessional Kt/V | 1.29 ± 0.21 |
Ultrafiltration volume (litres) | 1.7 [1.4] |
Clinical Assessment of Volume | |
Pre-dialysis Systolic BP (mmHg) | 151 ± 25 |
Pre-dialysis Diastolic BP (mm Hg) | 79 ± 15 |
Post-dialysis Systolic BP (mmHg) | 137 ± 26 |
Antihypertensive medication (%) | 74 |
Oedema (%) | 37 |
JVP > 3 cm (%) | 38 |
Basal Crepitations (%) | 54 |
Bioimpedance Parameters | |
ECFV (l) | 17.91 ± 3.98 |
Ideal ECFV (Chamney) | 17.09 ± 4.03 |
Excess ECFV | 0.82 ± 2.46 |
Natriuretic Peptide levels | |
Pre-dialysis ANP (pmol/l) | 169 [208] |
Post-dialysis ANP (pmol/l) | 79 [106] |
Pre-dialysis BNP (pmol/l) | 325 [1206] |